Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...

Sandoz launches biosimilar Pyzchiva in US, offering new treatment for around 12 million patients: Basel Tuesday, February 25, 2025, 14:00 Hrs [IST] Sandoz, the global leader in ge ...

The mass resignation of engineers, data scientists, and product managers is a temporary setback for Musk and the Republican ...

Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.

More than 20 civil service employees resigned Tuesday from Elon Musk’s Department of Government Efficiency, saying they ...

Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they ...

Report TRUMP FIRST 100 DAYS© Greg Nash, The Hill Trump says Ukraine deal is close after Russia vote IT’S A CRITICAL WEEK for ...

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...

The ‘London’ Bus theory goes that if one takeover emerges in a particular sector, then others will follow in quick succession ...